US · Healthcare · Medical Distribution
EPS came in at 2.91 against a street estimate of 2.42 — a beat of 20.2%.
Analysts rate Cardinal Health Inc a buy (14 buy, 3 hold, 0 sell out of 17) with an average price target of $271.47.
| Fund | Stake |
|---|---|
| BlackRock Inc | 11.44% |
| Vanguard Capital Management, LLC | 6.60% |
| Wellington Management Company LLP | 6.42% |
| Vanguard Portfolio Management, LLC | 5.92% |
| State Street Corp | 5.17% |
| Geode Capital Management, LLC | 2.80% |
| Amvescap Plc. | 2.05% |
| Morgan Stanley - Brokerage Accounts | 2.00% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q2 FY2027 HEADLINE NUMBERS • Cardinal Health reaffirmed fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60. • The company reaffirmed its long-term non | 2026-10-01 |
| Proxy statement · Q2 FY2027 CARDINAL HEALTH, INC. – PROXY STATEMENT SUMMARY CEO TOTAL COMPENSATION & CHANGE • Jason M. Hollar (CEO) Total Compensation for Fiscal 2026: Document | 2026-09-21 |
| Annual report FY2026 CARDINAL HEALTH, INC. - FISCAL 2026 10-K SUMMARY HEADLINE NUMBERS • Total Revenue: $254.2 billion in fiscal 2026, up 14% from $222.6 billion in fisc | 2026-08-11 |
| Results announced · Q1 FY2027 CARDINAL HEALTH – FISCAL YEAR 2026 RESULTS SUMMARY HEADLINE NUMBERS • Fourth quarter revenue $63.7 billion, up 6% year-over-year • Fourth quarter GA | 2026-08-11 |
| Material agreement · Q1 FY2027 CARDINAL HEALTH, INC. — FORM 8-K SUMMARY HEADLINE NUMBERS • New $4.0 billion unsecured revolving credit facility established August 7, 2026 • Facili | 2026-08-11 |
| Board / officer change · Q1 FY2027 CARDINAL HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Cardinal Health appointed Anita Zielinski as Chief Accounting Officer effective November | 2026-08-05 |
| Quarterly report · Q3 FY2026 CARDINAL HEALTH, INC. – Q3 FISCAL 2026 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Revenue (9 months ended March 31, 2026): $190.6 billion | 2026-04-30 |
| Results announced · Q4 FY2026 CARDINAL HEALTH Q3 FY2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue increased 11% to $60.9 billion in Q3 FY2026 vs. $54.9 billion in Q3 FY2025 • G | 2026-04-30 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.52 / share ex-date Oct 1, 2026 · pay Oct 15, 2026 | 2026-10-01 |
| Dividend | $0.52 / share ex-date Jul 1, 2026 · pay Jul 15, 2026 | 2026-07-01 |
| Dividend | $0.51 / share ex-date Apr 1, 2026 · pay Apr 15, 2026 | 2026-04-01 |
| Dividend | $0.51 / share ex-date Jan 2, 2026 · pay Jan 15, 2026 | 2026-01-02 |
| Dividend | $0.51 / share ex-date Oct 1, 2025 · pay Oct 15, 2025 | 2025-10-01 |
| Announcement | Date |
|---|---|
| Extended pharmaceutical distribution agreements with CVS Health through June 2032 Cardinal Health announced on October 1, 2026 that it has signed a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032. This is a s | 2026-10-01 |
| Updated fiscal year 2026 non-GAAP earnings per share outlook Cardinal Health announced an update to its fiscal year 2026 non-GAAP earnings per share (EPS) outlook on January 13, 2026. The company also disclosed it will present at the 44th Annual J.P. | 2026-01-13 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cardinal Health Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.